A citation-based method for searching scientific literature

Minnatallah Al-Yozbaki, Ibtissam Jabre, Naeem H Syed, Cornelia M Wilson. Semin Cancer Biol 2022
Times Cited: 3







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Chemopreventive properties of the ethanol extract of chinese licorice (Glycyrrhiza uralensis) root: induction of apoptosis and G1 cell cycle arrest in MCF-7 human breast cancer cells.
Eun-Hye Jo, Sung-Hoon Kim, Jeong-Chan Ra, Sung-Ran Kim, Sung-Dae Cho, Ji-Won Jung, Se-Ran Yang, Joon-Suk Park, Jae-Woong Hwang, Okezie I Aruoma,[...]. Cancer Lett 2005
70
33

CD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti-PD-1 Treatment.
Jarem Edwards, James S Wilmott, Jason Madore, Tuba Nur Gide, Camelia Quek, Annie Tasker, Angela Ferguson, Jinbiao Chen, Rehana Hewavisenti, Peter Hersey,[...]. Clin Cancer Res 2018
202
33

Anti-Proliferative and Pro-Apoptotic Effects of Licochalcone A through ROS-Mediated Cell Cycle Arrest and Apoptosis in Human Bladder Cancer Cells.
Su Hyun Hong, Hee-Jae Cha, Hyun Hwang-Bo, Min Yeong Kim, So Young Kim, Seon Yeong Ji, JaeHun Cheong, Cheol Park, Hyesook Lee, Gi-Young Kim,[...]. Int J Mol Sci 2019
30
33

Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.
J Ferlay, M Colombet, I Soerjomataram, C Mathers, D M Parkin, M Piñeros, A Znaor, F Bray. Int J Cancer 2019
33

2
50

BATMAN-TCM: a Bioinformatics Analysis Tool for Molecular mechANism of Traditional Chinese Medicine.
Zhongyang Liu, Feifei Guo, Yong Wang, Chun Li, Xinlei Zhang, Honglei Li, Lihong Diao, Jiangyong Gu, Wei Wang, Dong Li,[...]. Sci Rep 2016
357
33

IGDB.NSCLC: integrated genomic database of non-small cell lung cancer.
Sen Kao, Cheng-Kai Shiau, De-Leung Gu, Chun-Ming Ho, Wen-Hui Su, Chian-Feng Chen, Chi-Hung Lin, Yuh-Shan Jou. Nucleic Acids Res 2012
17
33


Mechanisms regulating T-cell infiltration and activity in solid tumors.
E Lanitis, D Dangaj, M Irving, G Coukos. Ann Oncol 2017
187
33

Inflammation and tumor progression: signaling pathways and targeted intervention.
Huakan Zhao, Lei Wu, Guifang Yan, Yu Chen, Mingyue Zhou, Yongzhong Wu, Yongsheng Li. Signal Transduct Target Ther 2021
168
33


A systematic prediction of multiple drug-target interactions from chemical, genomic, and pharmacological data.
Hua Yu, Jianxin Chen, Xue Xu, Yan Li, Huihui Zhao, Yupeng Fang, Xiuxiu Li, Wei Zhou, Wei Wang, Yonghua Wang. PLoS One 2012
239
33


Immunotherapy and tumor microenvironment.
Haidong Tang, Jian Qiao, Yang-Xin Fu. Cancer Lett 2016
169
33

Cyclin D-Cdk4,6 Drives Cell-Cycle Progression via the Retinoblastoma Protein's C-Terminal Helix.
Benjamin R Topacio, Evgeny Zatulovskiy, Sandra Cristea, Shicong Xie, Carrie S Tambo, Seth M Rubin, Julien Sage, Mardo Kõivomägi, Jan M Skotheim. Mol Cell 2019
103
33

PARP inhibition enhances tumor cell-intrinsic immunity in ERCC1-deficient non-small cell lung cancer.
Roman M Chabanon, Gareth Muirhead, Dragomir B Krastev, Julien Adam, Daphné Morel, Marlène Garrido, Andrew Lamb, Clémence Hénon, Nicolas Dorvault, Mathieu Rouanne,[...]. J Clin Invest 2019
158
33

Genetics of lipid metabolism in prostate cancer.
Ninu Poulose, Francesca Amoroso, Rebecca E Steele, Reema Singh, Chee Wee Ong, Ian G Mills. Nat Genet 2018
16
33

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients.
Roy S Herbst, Jean-Charles Soria, Marcin Kowanetz, Gregg D Fine, Omid Hamid, Michael S Gordon, Jeffery A Sosman, David F McDermott, John D Powderly, Scott N Gettinger,[...]. Nature 2014
33


A study on p16, pRb, cdk4 and cyclinD1 expression in non-small cell lung cancers.
K Lingfei, Y Pingzhang, L Zhengguo, G Jianhua, Z Yaowu. Cancer Lett 1998
29
33

Cyclin D-CDK4 relieves cooperative repression of proliferation and cell cycle gene expression by DREAM and RB.
Amy E Schade, Matthew G Oser, Hilary E Nicholson, James A DeCaprio. Oncogene 2019
28
33


Isoliquiritigenin inhibits the growth of prostate cancer.
Motohiro Kanazawa, Yoshiko Satomi, Yoichi Mizutani, Osamu Ukimura, Akihiro Kawauchi, Toshiyuki Sakai, Masaki Baba, Toru Okuyama, Hoyoku Nishino, Tsuneharu Miki. Eur Urol 2003
112
33

Glycyrrhizin Suppresses the Growth of Human NSCLC Cell Line HCC827 by Downregulating HMGB1 Level.
Xiaojin Wu, Weitao Wang, Yuanyuan Chen, Xiangqun Liu, Jindong Wang, Xiaobin Qin, Dawei Yuan, Tao Yu, Guangxia Chen, Yanyan Mi,[...]. Biomed Res Int 2018
16
33

Lipid metabolism and cancer.
Xueli Bian, Rui Liu, Ying Meng, Dongming Xing, Daqian Xu, Zhimin Lu. J Exp Med 2021
74
33

The Immune Landscape of Cancer.
Vésteinn Thorsson, David L Gibbs, Scott D Brown, Denise Wolf, Dante S Bortone, Tai-Hsien Ou Yang, Eduard Porta-Pardo, Galen F Gao, Christopher L Plaisier, James A Eddy,[...]. Immunity 2018
33


Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade.
Yoshiko Iwai, Masayoshi Ishida, Yoshimasa Tanaka, Taku Okazaki, Tasuku Honjo, Nagahiro Minato. Proc Natl Acad Sci U S A 2002
33

Large-scale Direct Targeting for Drug Repositioning and Discovery.
Chunli Zheng, Zihu Guo, Chao Huang, Ziyin Wu, Yan Li, Xuetong Chen, Yingxue Fu, Jinlong Ru, Piar Ali Shar, Yuan Wang,[...]. Sci Rep 2015
61
33

Targeting CDK4/6 in patients with cancer.
Erika Hamilton, Jeffrey R Infante. Cancer Treat Rev 2016
237
33

T-cell-based breast cancer immunotherapy.
Karolina Pilipow, Abbass Darwich, Agnese Losurdo. Semin Cancer Biol 2021
13
33

Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity.
Chia-Wei Li, Seung-Oe Lim, Weiya Xia, Heng-Huan Lee, Li-Chuan Chan, Chu-Wei Kuo, Kay-Hooi Khoo, Shih-Shin Chang, Jong-Ho Cha, Taewan Kim,[...]. Nat Commun 2016
473
33

Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance.
Jinfang Zhang, Xia Bu, Haizhen Wang, Yasheng Zhu, Yan Geng, Naoe Taira Nihira, Yuyong Tan, Yanpeng Ci, Fei Wu, Xiangpeng Dai,[...]. Nature 2018
446
33

Immune regulation of cancer.
Mary L Disis. J Clin Oncol 2010
298
33


A mouse model for SARS-CoV-2-induced acute respiratory distress syndrome.
Weiqi Hong, Jingyun Yang, Zhenfei Bi, Cai He, Hong Lei, Wenhai Yu, Yun Yang, Changfa Fan, Shuaiyao Lu, Xiaozhong Peng,[...]. Signal Transduct Target Ther 2021
104
33

Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe Disease.
Valentina Cappello, Laura Marchetti, Paola Parlanti, Silvia Landi, Ilaria Tonazzini, Marco Cecchini, Vincenzo Piazza, Mauro Gemmi. Sci Rep 2016
33

CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade.
Limo Chen, Lixia Diao, Yongbin Yang, Xiaohui Yi, B Leticia Rodriguez, Yanli Li, Pamela A Villalobos, Tina Cascone, Xi Liu, Lin Tan,[...]. Cancer Discov 2018
243
33

Licorice: A Potential Herb in Overcoming SARS-CoV-2 Infections.
Swee Li Ng, Kooi-Yeong Khaw, Yong Sze Ong, Hui Poh Goh, Nurolaini Kifli, Siew Phooi Teh, Long Chiau Ming, Vijay Kotra, Bey Hing Goh. J Evid Based Integr Med 2021
9
33

Peptide-based materials for cancer immunotherapy.
Lu Zhang, Yanyu Huang, Aaron Raymond Lindstrom, Tzu-Yin Lin, Kit S Lam, Yuanpei Li. Theranostics 2019
35
33

Molecular imaging of the tumor microenvironment.
Zhuxian Zhou, Zheng-Rong Lu. Adv Drug Deliv Rev 2017
107
33

Integrating tumor microenvironment with cancer molecular classifications.
Etienne Becht, Aurélien de Reyniès, Wolf H Fridman. Genome Med 2015
2
50

HDAC Inhibitors Enhance T-Cell Chemokine Expression and Augment Response to PD-1 Immunotherapy in Lung Adenocarcinoma.
Hong Zheng, Weipeng Zhao, Cihui Yan, Crystina C Watson, Michael Massengill, Mengyu Xie, Chris Massengill, David R Noyes, Gary V Martinez, Roha Afzal,[...]. Clin Cancer Res 2016
185
33


Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression.
Xin Jin, Donglin Ding, Yuqian Yan, Hui Li, Bo Wang, Linlin Ma, Zhenqing Ye, Tao Ma, Qiang Wu, Daniel N Rodrigues,[...]. Mol Cell 2019
126
33

Systems pharmacology: a combination strategy for improving efficacy of PD-1/PD-L1 blockade.
Chunli Zheng, Yue Xiao, Chuang Chen, Jinglin Zhu, Ruijie Yang, Jiangna Yan, Ruifei Huang, Wei Xiao, Yonghua Wang, Chao Huang. Brief Bioinform 2021
3
33

CDK4/6 inhibition triggers anti-tumour immunity.
Shom Goel, Molly J DeCristo, April C Watt, Haley BrinJones, Jaclyn Sceneay, Ben B Li, Naveed Khan, Jessalyn M Ubellacker, Shaozhen Xie, Otto Metzger-Filho,[...]. Nature 2017
693
33

TCMSP: a database of systems pharmacology for drug discovery from herbal medicines.
Jinlong Ru, Peng Li, Jinan Wang, Wei Zhou, Bohui Li, Chao Huang, Pidong Li, Zihu Guo, Weiyang Tao, Yinfeng Yang,[...]. J Cheminform 2014
33

Deubiquitination and Stabilization of PD-L1 by CSN5.
Seung-Oe Lim, Chia-Wei Li, Weiya Xia, Jong-Ho Cha, Li-Chuan Chan, Yun Wu, Shih-Shin Chang, Wan-Chi Lin, Jung-Mao Hsu, Yi-Hsin Hsu,[...]. Cancer Cell 2016
381
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.